Children's Oncology Group's 2023 blueprint for research: Rare tumors

the Children's Oncology Group Rare Tumor Committee

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The Children's Oncology Group (COG) Rare Tumor Committee includes the Infrequent Tumor and Retinoblastoma subcommittees, encompassing a wide range of extracranial solid tumors that do not fall within another COG disease committee. Current therapeutic trial development focuses on nasopharyngeal carcinoma, adrenocortical carcinoma, pleuropulmonary blastoma, colorectal carcinoma, melanoma, and thyroid carcinoma. Given the rarity of these tumors, novel strategies and international collaborative efforts are necessary to advance research and improve outcomes.

Original languageEnglish (US)
Article numbere30574
JournalPediatric Blood and Cancer
Volume70
Issue numberS6
DOIs
StatePublished - Sep 2023
Externally publishedYes

Keywords

  • Adrenocortical carcinoma
  • Children's Oncology Group
  • colorectal carcinoma
  • nasopharyngeal carcinoma
  • pleuropulmonary blastoma
  • rare cancer
  • rare tumor
  • retinoblastoma
  • thyroid cancer

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Children's Oncology Group's 2023 blueprint for research: Rare tumors'. Together they form a unique fingerprint.

Cite this